Atlas Trials

Rhenium-188-HEDP vs. Radium-223-chloride in Patients With Advanced Prostate Cancer Refractory to Hormonal Therapy

Clinical trial NCT03458559 · UNKNOWN

Trial details

NCT number
NCT03458559
Sponsor
Amsterdam UMC, location VUmc
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Prostate Cancer Metastatic to Bone
Start date
2018-05-16
Primary completion
2022-05-16
Enrollment
402

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.